ACTINIUM PHARMACEUTICALS, INC. Deferred Tax Assets, Deferred Income
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Deferred Tax Assets, Deferred Income of $8.55 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Deferred Income $8.55M.
- 2024-12-31: Deferred Tax Assets, Deferred Income $8.22M.
- 2023-12-31: Deferred Tax Assets, Deferred Income $8.22M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2025-12-31 | $8.55M 10-K · filed 2026-03-30 |
| 2024-12-31 | $8.22M 10-K · filed 2026-03-30 |
| 2023-12-31 | $8.22M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |